mimic gut hormones to enhance insulin release in diabetes
Incretin mimetics are a class of medications used to treat type 2 diabetes by mimicking the action of incretin hormones, which stimulate insulin release in response to meals. These drugs help lower blood sugar levels by enhancing insulin secretion, slowing gastric emptying, and reducing appetite.
— no results